BIWEEKLY PACLITAXEL AND CISPLATIN - A PHASE-I/II STUDY IN THE FIRST-LINE TREATMENT OF METASTATIC BREAST-CANCER

被引：0
|
作者：
OREILLY, SE
GELMON, KA
机构：
来源：
SEMINARS IN ONCOLOGY | 1995年 / 22卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：109 / 111
页数：3
相关论文
共 50 条
  • [31] Adding Bevacizumab to Paclitaxel in the First-Line Treatment of Metastatic Breast Cancer
    Fox, Kevin R.
    CURRENT ONCOLOGY REPORTS, 2009, 11 (01) : 5 - 6
  • [32] A phase II study of biweekly S-1 and paclitaxel (SPA) as first-line chemotherapy in patients with metastatic or advanced gastric cancer
    Haiping Jiang
    Jiong Qian
    Peng Zhao
    Xiaochen Zhang
    Yi Zheng
    Chenyu Mao
    Yulong Zheng
    Linghong Chen
    Yao Wang
    Haibo Mou
    Weijia Fang
    Lisong Teng
    Nong Xu
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 197 - 203
  • [33] Interim analysis of a phase II study of epirubicin and paclitaxel as first-line therapy in patients with metastatic breast cancer
    Luck, HJ
    Thomssen, C
    duBois, A
    Lisboa, BW
    Untch, M
    Kuhnle, H
    Konecny, G
    Janicke, F
    Meerpohl, HG
    Lindner, C
    Hecker, D
    Diergarten, K
    SEMINARS IN ONCOLOGY, 1996, 23 (01) : 33 - 36
  • [34] Exemestane and Chemotherapy as First-line Treatment of Metastatic Breast Cancer: Results of a Phase II Study
    de la Haba-Rodriguez, Juan
    Gonzalez Mancha, Rosario
    Perez Manga, Gumersindo
    Aranda Aguilar, Enrique
    Baena Canada, Jose Manuel
    Sanchez Rovira, Pedro
    Alba Conejo, Emilio
    CLINICAL BREAST CANCER, 2010, 10 (04) : 313 - 317
  • [35] Phase II study of vinorelbine and capecitabine as first-line treatment for metastatic breast cancer.
    El-Sadda, Wael
    Halim, Inas Ibraheim Abdel
    Aziz, Mohamed Abdel
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [36] A phase I/II study of vinorelbine, doxorubicin, and methotrexate with leucovorin rescue as first-line treatment for metastatic breast cancer
    Subramanyan, S
    Abeloff, MD
    Bond, SE
    Davidson, NE
    Fetting, JH
    Gordon, GB
    Kennedy, MJ
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1999, 43 (06) : 497 - 502
  • [37] A phase I/II study of vinorelbine, doxorubicin, and methotrexate with leucovorin rescue as first-line treatment for metastatic breast cancer
    Smitha Subramanyan
    Martin D. Abeloff
    Stephen E. Bond
    Nancy E. Davidson
    John H. Fetting
    Gary B. Gordon
    M. John Kennedy
    Cancer Chemotherapy and Pharmacology, 1999, 43 : 497 - 502
  • [38] A phase II study of first-line biweekly capecitabine and bevacizumab in elderly patients with metastatic colorectal cancer
    Puthillath, Ajithkumar
    Mashtare, Terry, Jr.
    Wilding, Gregory
    Khushalani, Nikhil
    Steinbrenner, Lynn
    Ross, Mary Ellen
    Romano, Karen
    Wisniewski, Michelle
    Fakih, Marwan G.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2009, 71 (03) : 242 - 248
  • [39] A phase II trial of weekly paclitaxel, 5-fluorouracil, and leucovorin as first-line treatment for metastatic breast cancer
    Loesch, DM
    Asmar, L
    Canfield, VA
    Parker, GA
    Hynes, HE
    Ellis, PG
    Ferri, WA
    Robert, NJ
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 77 (02) : 115 - 123
  • [40] Phase II trial of weekly nab-paclitaxel in combination with bevacizumab as first-line treatment in metastatic breast cancer
    Danso, M. A.
    Blum, J. L.
    Robert, N. J.
    Krekow, L.
    Rotche, R.
    Smith, D. A.
    Richards, P.
    Anderson, T.
    Richards, D. A.
    O'Shaughnessy, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345